Lataa...
Lutetium-labelled peptides for therapy of neuroendocrine tumours
Treatment with radiolabelled somatostatin analogues is a promising new tool in the management of patients with inoperable or metastasized neuroendocrine tumours. Symptomatic improvement may occur with (177)Lu-labelled somatostatin analogues that have been used for peptide receptor radionuclide thera...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer-Verlag
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304065/ https://ncbi.nlm.nih.gov/pubmed/22388631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-011-2039-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|